Editas Medicine (EDIT) Interest & Investment Income (2015 - 2025)
Editas Medicine (EDIT) reported Interest & Investment Income of $1.8 million for Q3 2025, down 48.13% year-over-year from $3.5 million in Q3 2024, and down 12.27% quarter-over-quarter from $2.1 million in Q2 2025.
Editas Medicine (EDIT) Interest & Investment Income (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Interest & Investment Income data on file, last reported at $1.8 million in Q3 2025.
- Interest & Investment Income for Q3 2025 came in at $1.8 million, down 48.13% year-over-year; the trailing twelve-month figure through Sep 2025 was $7.8 million (down 56.38% YoY), and the FY2024 annual result was $14.1 million, down 19.95% from the prior year.
- Interest & Investment Income retreated to $1.8 million in Q3 2025 per EDIT's latest filing, from $2.1 million in the prior quarter.
- Over five years, Interest & Investment Income peaked at $5.1 million in Q3 2023 and troughed at $134000.0 in Q1 2021.
- A 5-year average of $2.3 million and a median of $2.1 million in 2025 frame the typical range for Interest & Investment Income.
- The sharpest annual moves came in 2021 and 2022: Interest & Investment Income sank 91.4% in 2021, then jumped 1449.71% in 2022.
- A 5-year view of Interest & Investment Income shows it stood at $175000.0 in 2021, then jumped by 1449.71% to $2.7 million in 2022, then jumped by 88.13% to $5.1 million in 2023, then sank by 76.46% to $1.2 million in 2024, then surged by 52.46% to $1.8 million in 2025.
- Business Quant data shows EDIT's Interest & Investment Income at $1.8 million in Q3 2025, $2.1 million in Q2 2025, and $2.7 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 597,319.59 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 40.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 305,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 103,341.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 114.80 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -14.79 Mn |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.83 Mn |
| Jun 30, 2025 | 2.09 Mn |
| Mar 31, 2025 | 2.72 Mn |
| Dec 31, 2024 | 1.20 Mn |
| Sep 30, 2024 | 3.53 Mn |
| Jun 30, 2024 | 4.30 Mn |
| Mar 31, 2024 | 5.04 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 5.14 Mn |
| Jun 30, 2023 | 3.81 Mn |
| Mar 31, 2023 | 3.51 Mn |
| Dec 31, 2022 | 2.71 Mn |
| Sep 30, 2022 | 1.79 Mn |
| Jun 30, 2022 | 546,000.00 |
| Mar 31, 2022 | 469,000.00 |
| Dec 31, 2021 | 175,000.00 |
| Sep 30, 2021 | 152,000.00 |
| Jun 30, 2021 | 146,000.00 |
| Mar 31, 2021 | 134,000.00 |
| Dec 31, 2020 | 228,000.00 |